Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

15 results
Display

Low-grade lymphoma: Beyond fludarabine-single therapy

Park E

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent(R) Technology

Matsushita T

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A controversial conclusion regarding primary extranodal diffuse large B-cell lymphoma

Park SK, Yun J, Kim SH, Hong DS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fortuitous detection of esophageal pneumatosis in a neutropenic patient

Yahng SA, Kim HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Plasma cell leukemia with rouleaux formation involving neoplastic cells and RBC

Cho SR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of follicular B-cell lymphoma treated using clarithromycin

Ohe M, Hashino S

We report a case of follicular B-cell lymphoma (FL) treated successfully using clarithromycin (CAM). A 44-year-old man who presented with lymphadenopathy was diagnosed with FL after a histological examination of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genotypic influence of alpha-deletions on the phenotype of Indian sickle cell anemia patients

Pandey S, Pandey S, Mishra RM, Sharma M, Saxena R

BACKGROUND: Some reports have shown that co-inheritance of alpha-thalassemia and sickle cell disease improves hematological parameters and results in a relatively mild clinical picture for patients; however, the exact molecular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Kim JS, Kim SJ, Cheong JW, Kim Y, Hwang DY, Yoon S, Jang J, Hyun SY, Min YH

BACKGROUND: BAFF (B cell-activating factor) and APRIL (a proliferation-inducing ligand) are members of the tumor necrosis factor family and promote B cell survival and proliferation. We evaluated the correlation between...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent advances in the path toward the cure for chronic myeloid leukemia

Kim DW

Through the phase 3 International Randomized Study of Interferon vs. STI571 (IRIS) trial, imatinib emerged as the standard treatment for chronic myeloid leukemia (CML) and has successfully prolonged the duration...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New clinical score for disease activity at diagnosis in Langerhans cell histiocytosis

Choi WI, Jeong YC, Kim SY, Kim SD, Pribis JP, Kim HJ, Koh KN, Im HJ, Lee YH, Seo JJ

BACKGROUND: The clinical presentation and course of Langerhans cell histiocytosis (LCH) are variable, ranging from an isolated, spontaneously remitting bone lesion to multisystem disease with risk organ involvement. Treatment of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphoma

Ahn JS, Yang DH, Jung SH, Bae SY, Tran HT, Park HC, Kim HN, Kim YK, Kim HJ, Lee JJ

BACKGROUND: The clinical efficacy and safety of fludarabine combination chemotherapy was investigated for the treatment of previously untreated patients with low-grade (NHL). METHODS: Twenty-five patients who were newly diagnosed as low-grade...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of anti-mitochondrial antibodies in a patient with chronic graft-versus-host disease following hematopoietic stem cell transplantation

Lee DH, Huh SJ, Yoon HH, Lee SW, Kim KH, Kim SH

Recent studies indicate that patients with chronic graft-versus-host disease (GVHD) are not expected to show positivity for anti-mitochondrial antibody (AMA), which is a specific disease marker for primary biliary cirrhosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of chronic graft-versus-host disease: Past, present and future

Martin PJ, Inamoto Y, Carpenter , Lee SJ, Flowers ME

Chronic GVHD was recognized as a complication of allogeneic hematopoietic cell transplantation more than 30 years ago, but progress has been slowed by the limited insight into the pathogenesis of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The prevalence of anemia and iron depletion in the population aged 10 years or older

Kim SK, Kang HS, Kim CS, Kim YT

BACKGROUND: Anemia and iron depletion continue to be common disorders in the world. This study was aimed at assessing the prevalence of anemia and iron depletion in apparently healthy Koreans...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier

Schiffer M, Kielstein

On April 23, 1951, a 30-year-old woman received the first intentional ABOi (ABO incompatible) renal transplantation in Boston. At that time, it was commonly believed that intensely rinsing the graft...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr